These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7870872)

  • 21. Pharmacological profile of a potential anxiolytic: AP159, a new benzothieno-pyridine derivative.
    Nagatani T; Yamamoto T; Takao K; Hashimoto S; Kasahara K; Sugihara T; Ueki S
    Psychopharmacology (Berl); 1991; 104(4):432-8. PubMed ID: 1723527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex.
    Seo JJ; Lee SH; Lee YS; Kwon BM; Ma Y; Hwang BY; Hong JT; Oh KW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1363-9. PubMed ID: 17698274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of non-sedative anxiolytic drugs on responses to GABA and on diazepam-induced enhancement of these responses on mouse neurones in cell culture.
    De Deyn PP; Macdonald RL
    Br J Pharmacol; 1988 Sep; 95(1):109-20. PubMed ID: 2905900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N,N'-dicyclohexylsulfamide and N,N'-diphenethylsulfamide are anticonvulsant sulfamides with affinity for the benzodiazepine binding site of the GABA(A) receptor and anxiolytic activity in mice.
    Wasowski C; Gavernet L; Barrios IA; Villalba ML; Pastore V; Samaja G; Enrique A; Bruno-Blanch LE; Marder M
    Biochem Pharmacol; 2012 Jan; 83(2):253-9. PubMed ID: 22056620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.
    Jones GH; Schneider C; Schneider HH; Seidler J; Cole BJ; Stephens DN
    Psychopharmacology (Berl); 1994 Mar; 114(2):191-9. PubMed ID: 7838907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
    Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of behavioral and central BDZ binding profile in three rat lines.
    Onaivi ES; Maguire PA; Tsai NF; Davies MF; Loew GH
    Pharmacol Biochem Behav; 1992 Nov; 43(3):825-31. PubMed ID: 1360163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
    Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
    Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
    Gannon RL; Lungwitz E; Batista N; Hester I; Huntley C; Peacock A; Delagrange P; Millan MJ
    Behav Brain Res; 2011 Mar; 218(1):8-14. PubMed ID: 21094664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice.
    Raud S; Rünkorg K; Veraksits A; Reimets A; Nelovkov A; Abramov U; Matsui T; Bourin M; Volke V; Kõks S; Vasar E
    Psychopharmacology (Berl); 2003 Aug; 168(4):417-25. PubMed ID: 12709779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea.
    Wolfman C; Viola H; Paladini A; Dajas F; Medina JH
    Pharmacol Biochem Behav; 1994 Jan; 47(1):1-4. PubMed ID: 7906886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacological profile of chlordesmethyldiazepam and other benzodiazepines.
    Chojnacka-Wójcik E; Tatarczyńska E; Wiczyńska B; Lewandowska A; Przegaliński E
    Pol J Pharmacol Pharm; 1986; 38(2):207-13. PubMed ID: 2875452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent.
    Patel JB; Malick JB
    Eur J Pharmacol; 1982 Mar; 78(3):323-33. PubMed ID: 6121711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.